Vaccines to block COVID-19 that are in development by Moderna, Pfizer, AstraZeneca and others, and that are currently in Phase III clinical trials, may not do as well covering people of Black or Asian ...
A platform from researchers at the Massachusetts Institute of Technology could propose personalized sets of excipients for people with allergies. (RapidEye/E+/Getty Images) Massachusetts Institute of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results